BlackRock, Inc. (NYSE:BLK – Get Free Report) was up 0.8% during trading on Tuesday . The stock traded as high as $769.27 and last traded at $766.27. Approximately 102,897 shares traded hands during trading, a decline of 83% from the average daily volume of 623,260 shares. The stock had previously closed at $760.11.

New York State Common Retirement Fund reduced its stake in shares of Fastenal (NASDAQ:FAST – Free Report) by 4.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 854,211 shares of the company’s stock after selling 40,037 shares during the period. New York State Common Retirement Fund owned approximately 0.15% of Fastenal worth $55,327,000 at the end of the most recent quarter.

Mattel (NASDAQ:MAT – Free Report) had its target price hoisted by Citigroup from $25.00 to $26.00 in a research note released on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock.

Illinois Municipal Retirement Fund lowered its stake in Molson Coors Beverage (NYSE:TAP – Free Report) by 35.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 129,943 shares of the company’s stock after selling 70,205 shares during the period. Illinois Municipal Retirement Fund owned about 0.06% of Molson Coors Beverage worth $7,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Jennison Associates LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 49.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,208,830 shares of the company’s stock after buying an additional 399,961 shares during the period. Jennison Associates LLC owned about 0.27% of GE HealthCare Technologies worth $93,467,000 as of its most recent filing with the Securities and Exchange Commission.

Marriott International (NASDAQ:MAR – Free Report) had its target price decreased by Mizuho from $263.00 to $260.00 in a research report released on Tuesday morning, Benzinga reports. Mizuho currently has a neutral rating on the stock.

A number of other equities analysts have also recently weighed in on the stock. UBS Group lifted their price target on shares of Harley-Davidson from $29.00 to $39.00 and gave the stock a neutral rating in a research report on Friday, February 16th. Citigroup boosted their price objective on shares of Harley-Davidson from $36.00 to $37.00 and gave the company a neutral rating in a research report on Tuesday, February 27th. Bank of America boosted their price objective on shares of Harley-Davidson from $50.00 to $55.00 and gave the company a buy rating in a research report on Thursday, March 14th. BMO Capital Markets boosted their price objective on shares of Harley-Davidson from $45.00 to $50.00 and gave the company an outperform rating in a research report on Wednesday, April 3rd. Finally, DA Davidson boosted their price objective on shares of Harley-Davidson from $42.00 to $49.00 and gave the company a buy rating in a research report on Thursday, April 11th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Harley-Davidson presently has an average rating of Moderate Buy and a consensus price target of $47.14.

Kohl’s Co. (NYSE:KSS – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Traders bought 23,743 put options on the stock. This represents an increase of approximately 73% compared to the typical volume of 13,721 put options.

Devon Energy (NYSE:DVN – Get Free Report) had its price target boosted by Truist Financial from $66.00 to $69.00 in a report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the energy company’s stock. Truist Financial’s price target would suggest a potential upside of 32.36% from the company’s current price.

Foundry Partners LLC trimmed its stake in GSK plc (NYSE:GSK – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 222,589 shares of the pharmaceutical company’s stock after selling 27,560 shares during the quarter. Foundry Partners LLC’s holdings in GSK were worth $8,249,000 at the end of the most recent reporting period.